Wird geladen...
Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B
AIM: To investigate serum interleukin (IL)-38 level and its clinical role in predicting virological response (VR) to telbivudine (LdT) in patients with chronic hepatitis B (CHB). METHODS: The study participants were divided into two groups; one group consisted of 43 healthy controls (HCs) and the ot...
Gespeichert in:
| Veröffentlicht in: | World J Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4858634/ https://ncbi.nlm.nih.gov/pubmed/27182162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i18.4529 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|